Conjunctivitis, Giant Papillary
1 clinical trials · Condition
◉ Watch Conjunctivitis, Giant Papillary
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Safety and Efficacy of Lotemax Ophthalmic Suspension 0.5% (NCT01437982) | Bausch & Lomb Incorporated | 2010-08-05 |
Track Conjunctivitis, Giant Papillary automatically
Every clearance here is in the API, with alerts when new ones post.